The current investigation of participants in the DPT-1 and TN07 who probably have ongoing autoimmunity suggests that autoimmune processes involving HLA-DQ molecules are necessary for islet beta cell destruction, together with other subsequent processes (such as CD8 T cell attacks), leading at-risk individuals to progress to clinical type 1 diabetes. Here, CD8A is linked to type 1 diabetes mellitus.